100
Participants
Start Date
January 1, 2024
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Intermittent Theta-Burst Stimulation (iTBS)
Stimulation delivered using a Magstim RAPID2 stimulator. The target was the left DLPFC (F3 position). The protocol consisted of 20 sessions (5 days/week for 4 weeks) at 100% of the individual's motor threshold (MT), with each session delivering 2400 pulses.
Risperidone
Oral risperidone (Jiangsu Enhua Pharmaceutical Co., Ltd.) initiated at 1 mg/day and flexibly titrated based on efficacy and tolerability to a maximum of 6 mg/day.
Cognitive Behavioral Therapy (CBT)
Manualized CBT administered twice weekly for 12 weeks. The therapy comprised an initial individual phase (4 weeks) focusing on psychoeducation and a subsequent group phase (8 weeks) targeting social and emotional skills.
The First Hospital of Hebei Medical University, Shijiazhuang
The First Hospital of Hebei Medical University
OTHER